About IMBIO
Imbio is a medical imaging artificial intelligence company specializing in chronic lung and cardiothoracic disease analysis. The company develops advanced algorithms that extract quantitative data from standard CT scans and X-rays to enable earlier detection, more accurate diagnosis, and personalized treatment planning. Imbio's product portfolio includes Lung Density Analysis (both inspiratory and functional), Lung Texture Analysis, Pulmonary Hypertension Assessment, Airway Analysis, and Coronary Artery Calcification tools. The company's technology utilizes parametric response mapping and other advanced image analysis techniques to provide functional pictures of the lung, making it particularly useful for assessing conditions like chronic bronchitis, COPD, and interstitial lung diseases. Imbio serves physicians, radiologists, and healthcare systems globally through various deployment options including companion imaging integration. In December 2023, Imbio entered a binding agreement to be acquired by 4DMedical, an Australian respiratory imaging technology company, creating a comprehensive cardiothoracic image analysis portfolio. The combined entity aims to transform patient care by turning standard medical imaging into personalized medicine for discovering, diagnosing, treating, and managing respiratory conditions.
Mission & Story
Mission
AI to turn standard medical imaging into personalized medicine for transforming the way patients are discovered, diagnosed, treated, and managed
Clinical Focus
Medical conditions and clinical areas addressed by IMBIO.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by 4DMedical in December 2023. Distribution agreement with Blackford signed February 2024. TGA approval for CT:VQ received June 2024. Partnership with MEDICAL-NOTE for Italian market expansion 2021.
Awards & Recognition
NICE Medtech Innovation Briefing (MIB) issued for Lung Texture Analysis algorithm in September 2021
Key Partnerships
Social & Media
Follow on
Latest Updates
Imbio Partners with MEDICAL-NOTE to Expand Image Analysis Tool Offering to Clinicians across Italy
Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio
4DMedical Signs Distribution Agreement with Blackford
Olympus Makes SeleCT™ QCT Analysis Available Nationwide via the Nuance AI Marketplace to Increase Access to Spiration Valve System Therapy
Imbio Partners with Heart&Lung Health Ltd to Serve the UK Market with Enhanced Quantitative Imaging Services
Company Details
- Headquarters
- Minneapolis, MN, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.